Edition:
United States

Lee's Pharmaceutical Holdings Ltd (0950.HK)

0950.HK on Hong Kong Stock

6.12HKD
26 Sep 2017
Change (% chg)

HK$-0.07 (-1.13%)
Prev Close
HK$6.19
Open
HK$6.22
Day's High
HK$6.22
Day's Low
HK$6.10
Volume
223,000
Avg. Vol
298,666
52-wk High
HK$7.88
52-wk Low
HK$6.01

Chart for

About

Lee’s Pharmaceutical Holdings Limited is a Hong Kong-based investment holding company principally engaged in the development, manufacture, marketing and sales of pharmaceutical products. The Company operates through two segments. Proprietary Products segment is engaged in the manufacture and sales of self-developed pharmaceutica... (more)

Overall

Beta: 0.86
Market Cap(Mil.): HK$3,657.94
Shares Outstanding(Mil.): 590.94
Dividend: 0.03
Yield (%): 1.83

Financials

  Industry Sector
P/E (TTM): -- 30.47 15.77
EPS (TTM): -- -- --
ROI: -- 14.26 15.19
ROE: -- 15.57 13.80

BRIEF-Lee's Pharmaceutical Holdings says ‍interim dividend hk$0.034 per ordinary share​

* Hy profit attributable hk$78.690 million versus hk$68.311 million Source text for Eikon: Further company coverage:

Aug 24 2017

BRIEF-Lee's Pharmaceutical reports qtrly profit attributable HK$46.4 mln

* Qtrly profit attributable to owners of company HK$46.4 million versus HK$53.1 million

May 31 2017

BRIEF-Lee's Pharmaceutical says unit and COF enter shareholder loan agreement

* Lee's international to advance shareholder loan in principle amount of hk$10 million to cof at an interest rate of 4% per annum Source text (http://bit.ly/2pdwGIC) Further company coverage:

Apr 25 2017

Earnings vs. Estimates